Department of Genetics Publications for March 7-20, 2021
March 20, 2021
Department of Genetics faculty, postdocs, students and collaborators published ten papers during March 7-20, 2021.
Tag: UNC Genetics
Department of Genetics Town Hall Meeting – March 10, 2021
March 10, 2021
Highlights, service awards, personal reflections on the past year, covid vaccination updates, performance review process.
Department of Genetics Publications for February 21 – March 6, 2021
March 8, 2021
Department of Genetics faculty, postdocs, students and collaborators published twelve papers during February 21 – March 6, 2021.
Chancellor’s Science Scholars Program
January 29, 2021
Details about the UNC Chancellor’s Science Scholars Program can be found in the slides provided by Dr. Thomas Freeman, Executive Director. Department faculty are encouraged to get involved.
Department of Genetics Town Hall – January 27, 2021
January 29, 2021
Department metrics, covid-19 testing and vaccine guidance, how to volunteer in vaccine distribution centers.
Department of Genetics Publications for Nov. 29 – Dec. 12, 2020
December 14, 2020
Department of Genetics faculty, postdocs, students and collaborators published ten papers during November 29 – December 12, 2020.
Department of Genetics Town Hall – December 9, 2020
December 10, 2020
Compliance reminders, lab safety refresher, up-to-date covid testing guidelines starting JAN 2021.
Department of Genetics Publications for Nov. 15-28, 2020
November 30, 2020
Department of Genetics faculty, postdocs, students and collaborators published nine papers during November 15-28, 2020.
Department of Genetics Publications for November 1-14, 2020
November 16, 2020
Department of Genetics faculty, postdocs, students and collaborators published nine papers during November 1-14, 2020.
Department of Genetics Publications for October 11-31, 2020
November 2, 2020
Department of Genetics faculty, postdocs, students and collaborators published 18 papers during October 11-31, 2020. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, Parker...